E

Exenatide

Drug / MedicationMentioned in 1 video

An older, first-generation GLP-1 (Gen 1) receptor agonist, part of the triple therapy in the EDI Study and Qatar study, described as effective despite its age.

Videos Mentioning Exenatide

337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more

337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more

Peter Attia MD

An older, first-generation GLP-1 (Gen 1) receptor agonist, part of the triple therapy in the EDI Study and Qatar study, described as effective despite its age.